COPIC Medical Foundation Awards Grant to RxAssurance

The COPIC Medical Foundation announced today that it has awarded a grant to Denver-based prescription optimization company, RxAssurance. The grant will fund a study of the efficacy of RxAssurance’s prescription pain medication platform for improving patient safety and outcomes.

A recent study published in the Clinical Journal of Pain showed that patients often abuse their pain medications, with some of them obtaining them from multiple physicians and pharmacies, without the knowledge of those providers.

Deaths related to prescription painkiller use increased 313 percent over the past decade, according to the Substance Abuse and Mental Health Services Administration. In 2013 alone, 295 Coloradans died from overdoses of prescription opioids, more than those who died in drunk driving crashes.

The RxAssurance platform, OpiSafe, helps doctors and patients better manage the complexity of prescribing opioid medications safely. It administers baseline assessments of pain and function, performs risk stratification, generates provider-patient agreements, follows patients daily and tracks random urinalyses. The software also checks the Colorado Prescription Drug Monitoring Program database (PDMP) for doctors and creates one-page patient summary screens for each patient, including all relevant documentation.

“This grant will assist providers in more effectively managing and treating patients”, said Dr. Brian Harrington, Chair of the COPIC Medical Foundation’s Grants Committee. “We are confident the data compiled by this pilot program will lead to more effective pain management policies by providers, and give them credible data to work with in assessing each patient’s needs.”

The grant seeks to enroll 100 Colorado physicians who prescribe pain medications into a six-month, self-controlled study of physician use, satisfaction and guideline adherence. The system is designed to help providers (and patients with pain) achieve effective and safe guideline-adherent prescribing and use of opioids.

“This study will generate important evidence to show that physicians and patients using OpiSafe can, and will, more easily adhere to best-practice guidelines for opioid prescribing and achieve better outcomes,” according to Rob Valuck, PhD, RPh, Chief Strategy Officer at RxAssurance. “Our goal is to make it easier for doctors and patients to do the many things that are recommended, so that they can use pain medications safely and minimize risks.”

For more than two decades, COPIC Medical Foundation has provided grants totaling more than $5 million to programs and organizations that improve health care outcomes, patient safety and quality of care.

If you are a provider who would like to participate in this study, please contact copic@rxassurance.com. Learn more about OpiSafe at opisafe.com.

About COPIC Medical Foundation

Established in 1992, the COPIC Medical Foundation supports improved outcomes through grant funding focused on patient safety, quality of care, reducing medical errors, and disease management and transitions in care. The Foundation has provided more than $5 million in grants and directed donations. It also recognizes physicians for volunteer medical/community service each year and funds scholarships for medical students.

About RxAssurance

RxAssurance believes that technology can make a long lasting, positive impact on the wellbeing of patients. Knowing what happens when a patient leaves the care of their provider is a critical missing piece of the healthcare puzzle. Our solutions are designed to address this critical gap, bringing behavioral economics, the psychology of online user interaction and global availability together to keep patients working their way towards healthy habits that ensure safe and effective medication therapy outcomes. For more information, visit www.rxassurance.com.

Publication Details

Date: August 25, 2015

Source: 3rd Party

Author: RxAssurance

Type: Press Release